StockData

Tilray Brands vs Trulieve Cannabis

TLRY and TRLV side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How TLRY and TRLV compare

Trulieve Cannabis is the larger company, worth 5.8 times as much as Tilray Brands ($2.0B against $346M).

Tilray Brands grew revenue faster over the last twelve months (15.9% versus −3.9% for Trulieve Cannabis).

Tilray Brands scores higher on the StockData Score (11 against 5 for Trulieve Cannabis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricTLRYTRLV
Size and price
Market cap$346M$2.0B
Share price$2.34$10.33
Change, 1 year−79.3%68.0%
Change, 5 years−97.8%−64.6%
Beta (5Y)−0.170.01
Employees3,5955,000
StockData Score
Total score11 (better)5
Valuation score33
Growth score3 (better)0
Performance score3 (better)0
Health score22
Dividend score00
Valuation
P/S0.4× (better)1.7×
P/B0.2×–
P/FCF–9.8×
FCF yield–10.2%
Fair value$18.49$15.34
Margin of safety87.3% (better)32.7%
Growth
Revenue growth (TTM)15.9% (better)−3.9%
Revenue growth, 5Y average40.5% (better)17.8%
Profitability
Gross margin29.1%59.5% (better)
Operating margin−9.3% (better)−24.3%
Net margin−17.1%–
FCF margin–17.8%
Return on equity−10.4%–
Return on invested capital−5.0%–
Financial health
Debt / equity0.08–
Interest coverage–−4.9×
Current ratio1.885.94 (better)
Altman Z-score−2.240.40 (better)
Piotroski F-score3–
Dividends and buybacks
Buyback yield−45.6%–
Shareholder yield−45.6%0.00% (better)
Ownership
Held by institutions9.5%20.1%
Held by insiders2.0%5.3%
Insider net buying, 12 months−$164K (better)−$14.7M
Short interest, % of float13.5%2.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.